In the recent years it has been recognized that nitric oxide is an importan
t regulator of ocular blood flow. Nitric oxide is involved in the control o
f basal blood flow in the choroid, optic nerve and the retina. In addition,
nitric oxide mediates a number of vasodilator responses in ocular vessels
to agonists such as acetylcholine, bradykinin, histamine, substance P and i
nsulin. Nitric oxide also plays a role in hypercapnia-induced vasodilation
in the choroid and is a modulator of pressure autoregulation in this vascul
ar bed. Abnormalities of the L-arginine/nitric oxide system have been obser
ved in a variety of ocular diseases including glaucoma, diabetic retinopath
y and retinopathy of prematurity. This makes the L-arginine/nitric oxide pa
thway an attractive target for therapeutic interventions. Additional resear
ch is required, particularly in characterizing the role of the three nitric
oxide synthase isoforms in the control of ocular perfusion, to implement t
his concept into the clinical management of ocular diseases. (C) 2001 Elsev
ier Science Ltd. All rights reserved.